Numerous studies have demonstrated that CypA and its receptor CD147 are overexpressed in many cancers, including lung cancer, and that the activation of CypA/CD147-mediated intracellular downstream signaling pathways promotes the growth, metastasis, therapeutic resistance, and stem-like properties of cancer cells [14]. The gene discussed is PPIA; the disease is lung carcinoma.